Cao Y, Schnurr D P
Viral and Rickettsial Disease Laboratory, California State Department of Health Services, Berkeley 94704.
J Gen Virol. 1988 Jan;69 ( Pt 1):59-65. doi: 10.1099/0022-1317-69-1-59.
Persistent infection (PI) of YAC-1 cells by coxsackievirus B3 (CBV-3) was characterized. CBV-3 PIs were maintained for 7 months or more, although in two other cases cells were cured of virus at 6 and 6.5 months of PI. The titre of infectious virus peaked during the first week of the infection and then gradually decreased. The proportion of cells producing infectious centres increased to 100% by 48 h after infection, remained at that level up to the seventh day, and then rapidly decreased. Susceptibility to PI by CBV-3 varied widely among 40 clones from uninfected YAC-1 cells as judged by the yield of infectious virus at 6 weeks post-infection. None of the clones was completely lysed by the virus. Clones were not obtained from cells infected for 2 or 7 days. Of six clones obtained from cells infected for 14 days and 24 clones from cells infected for 6 weeks, none was producing virus and all were resistant to reinfection by CBV-3. Six of the clones were serially subcultured and all remained resistant for as long as they were maintained (5 months). During the course of the PI, viral variants which produced smaller plaques and required a longer incubation period for the development of visible plaques replaced the original viral population. Thus the PI involved a carrier culture with a large proportion of resistant cells. The resistant state did not require the continued presence of virus.
对柯萨奇病毒B3(CBV - 3)持续感染YAC - 1细胞的情况进行了表征。CBV - 3持续性感染(PI)可维持7个月或更长时间,不过在另外两例中,细胞在PI的6个月和6.5个月时病毒被清除。感染性病毒滴度在感染的第一周达到峰值,然后逐渐下降。产生感染中心的细胞比例在感染后48小时增加到100%,直到第七天保持在该水平,然后迅速下降。根据感染后6周感染性病毒的产量判断,未感染的YAC - 1细胞的40个克隆对CBV - 3的PI易感性差异很大。没有一个克隆被病毒完全裂解。未从感染2天或7天的细胞中获得克隆。从感染14天的细胞中获得了6个克隆,从感染6周的细胞中获得了24个克隆,这些克隆均未产生病毒,并且对CBV - 3的再次感染均具有抗性。其中6个克隆进行了连续传代培养,并且只要维持培养(5个月)它们就一直保持抗性。在PI过程中,产生较小噬斑且形成可见噬斑需要更长潜伏期的病毒变体取代了原始病毒群体。因此,PI涉及一种含有很大比例抗性细胞的载体培养物。抗性状态不需要病毒持续存在。